Wearable devices and hospital monitors may dominate conversations about remote health care, but a new Cornell-affiliated startup is betting its future on something almost invisible: radio waves.
SensVita, a company with technology licensed from Cornell, is developing a clinical-grade sensing platform that can track heart and lung health at home – without wires, without electrodes and without ever touching the skin.
The fledgling company has been admitted this fall to Cornell’s Praxis Center for Venture Development, an on-campus incubator that helps engineering, digital and physical science startups from Cornell become self-sufficient.
“SensVita has a noncontact, passive way of monitoring cardiac activity and breath activity,” said Bob Scharf, academic administrative director at Praxis. “The first human application would be for patients who are difficult to monitor – memory care patients or neonatal patients.”
